Abstract:Background Polygenic risk scores (PRS) have ushered in a new era in genetic epidemiology, offering insights into individual predispositions to a wide range of diseases. However, despite recent marked enhancements in their predictive power, there are still challenges that need to be overcome before PRS-based models can be broadly applied in the clinic, including sufficient accuracy, easy interpretability and portability across diverse populations. Methods Leveraging trans-ancestry genome-wide association study (GWAS) meta-analysis, we generated novel, diverse summary statistics for 30 medically-related traits which were used to benchmark the performance of six existing PRS algorithms using UK biobank. Observing that SBayesRC had the best overall performance but recognizing strengths in each method, we developed an ensemble PRS model using logistic regression to combine outputs from top-performing algorithms. This ensemble model was validated on the diverse eMERGE and PAGE MEC cohorts, and the performance was compared against current state-of-the-art PRS models. To enhance predictive accuracy for clinical application, we incorporated easily-accessible clinical characteristics such as age, gender, ancestry and risk factors, creating disease prediction models intended as prospective diagnostic tests, with easily interpretable positive or negative outcomes. Results Predictive performance of PRS models improved with trans-ancestry GWAS meta-analysis and was further enhanced by the ensemble model, which surpassed state-of-art PRS models. When applied to external cohorts, performance drops were minimal, indicating good calibration. After adding clinical characteristics, 12 out of 30 models surpassed 80% AUC. Further, 25 traits exceeded the diagnostic odds ratio (DOR) of 5 and 19 traits exceeded DOR of 10 for all ancestry groups, indicating high predictive value. The highest DOR in a population with a sufficient number of cases was 66.2 for Alzheimer's disease in Europeans. Our PRS model for coronary artery disease identified 55-80 times more true coronary events than rare pathogenic variant models, reinforcing its clinical potential. The polygenic component modulated the effect of high-risk rare variants, stressing the need to consider all genetic components in clinical settings. Conclusions Newly developed PRS-based disease prediction models have sufficient accuracy and portability to warrant consideration of being used in the clinic.

A Deep Ensemble Encoder Network Method for Improved Polygenic Risk Score Prediction

A Deep Learning-based Genome-wide Polygenic Risk Score for Common Diseases Identifies Individuals with Risk

One score to rule them all: regularized ensemble polygenic risk prediction with GWAS summary statistics

Stacked neural network for predicting polygenic risk score

An Ensemble Penalized Regression Method for Multi-ancestry Polygenic Risk Prediction

How to improve polygenic prediction from whole-genome sequencing data by leveraging predicted epigenomic features?

PRS-Net: Interpretable polygenic risk scores via geometric learning

DeepRisk: A deep learning approach for genome-wide assessment of common disease risk

Optimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models

Modeling gene interactions in polygenic prediction via geometric deep learning

Deep neural network improves the estimation of polygenic risk scores for breast cancer

A Non-Parametric Method for Building Predictive Genetic Tests on High-Dimensional Data

Deep Learning for Polygenic Risk Prediction

Feature Selection for Polygenic Risk Scores using Genetic Algorithm and Network Science

A data-adaptive Bayesian regression approach for polygenic risk prediction

Optimizing and benchmarking polygenic risk scores with GWAS summary statistics

Real-time dynamic polygenic prediction for streaming data

Leveraging Effect Size Distributions to Improve Polygenic Risk Scores Derived from Summary Statistics of Genome-Wide Association Studies.

An Improved Genome-Wide Polygenic Score Model for Predicting the Risk of Type 2 Diabetes

A comprehensive investigation of statistical and machine learning approaches for predicting complex human diseases on genomic variants